CRISPR/Cas9 Genome-Edited Autologous Hematopoietic Stem Cell Transplantation Therapies for Sickle Cell Disease
Yi Liu(The University of Texas Southwestern Medical Center), Susan C. Stevenson(Clinical Trial Investigators), Azeddine Elhajouji(Novartis (Switzerland)), Qí Zhāng(Beijing Institute of Genomics), Daher Ibrahim Aibo(Novartis (United States)), Craig Mickanin, Yi Yang(Chinese Academy of Sciences), K. Mueller(Novartis (Switzerland)), Karin Abitorabi(Novartis (Switzerland)), Timothy K. MacLachlan(Novartis (United States)), Daniel J. O’Connell(Harvard University), Vionnie W. Yu, Bo Han(Zhejiang University of Technology), Alberto Del Río-Espínola(Novartis (United States)), Nishit Patel(Intellia Therapeutics (United States)), Carsten Russ(Broad Institute), Madhura Panditrao
Cited by 0
Related Papers
A Draft Sequence of the Neandertal Genome
|Science|2010|4.6k
Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing
|Nature Biotechnology|2009|1.5k
Analyzing and minimizing PCR amplification bias in Illumina sequencing libraries
|Genome biology|2011|1.2k